1. Home
  2. VRCA vs NICM Comparison

VRCA vs NICM Comparison

Compare VRCA & NICM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Verrica Pharmaceuticals Inc.

VRCA

Verrica Pharmaceuticals Inc.

HOLD

Current Price

$5.54

Market Cap

107.5M

Sector

Health Care

ML Signal

HOLD

Logo Nicola Mining Inc. American Depositary Shares

NICM

Nicola Mining Inc. American Depositary Shares

N/A

Current Price

$6.35

Market Cap

120.4M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
VRCA
NICM
Founded
2013
N/A
Country
United States
Canada
Employees
N/A
25
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
107.5M
120.4M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
VRCA
NICM
Price
$5.54
$6.35
Analyst Decision
Buy
Analyst Count
2
0
Target Price
$17.00
N/A
AVG Volume (30 Days)
36.0K
2.6K
Earning Date
05-11-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$35,577,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$94.44
N/A
P/E Ratio
N/A
N/A
Revenue Growth
370.22
N/A
52 Week Low
$3.28
$5.97
52 Week High
$9.82
$6.48

Technical Indicators

Market Signals
Indicator
VRCA
NICM
Relative Strength Index (RSI) 40.43 47.58
Support Level $5.32 $5.97
Resistance Level $6.60 $6.40
Average True Range (ATR) 0.47 0.18
MACD -0.07 -0.00
Stochastic Oscillator 22.10 19.78

Price Performance

Historical Comparison
VRCA
NICM

About VRCA Verrica Pharmaceuticals Inc.

Verrica Pharmaceuticals Inc is a therapeutics company developing and commercializing medications for the treatment of dermatologic diseases, including skin cancers. Its commercial product and portfolio of product candidates are clinician administered therapies in areas of high unmet need. This product portfolio consists of one product with an approved indication for molluscum contagiosum, or molluscum, with the potential for several follow-on indications, as well as additional pipeline product candidates. Its commercial product, YCANTH (VP-102), for the treatment of molluscum in adult and pediatric patients two years of age and older. YCANTH (VP-102) is a proprietary drug-device combination that contains a GMP-controlled formulation of cantharidin.

About NICM Nicola Mining Inc. American Depositary Shares

Nicola Mining Inc is a junior exploration and custom milling company that is engaged in the business of identification, acquisition, and exploration of mineral property interests, together with custom milling partnerships at its Merritt Mill. The company holds interests in various claims at the following properties: the Treasure Mountain Property, New Craigmont Property, and Dominion Creek Property. Its portfolio of producing assets and development projects is mainly composed of copper, gold, and silver properties spread across British Columbia, Canada.

Share on Social Networks: